Press release
Natera Co-Founder and Executive Chairman Matthew Rabinowitz Named 2024 R&D Leader of the Year
AUSTIN, Texas--(BUSINESS WIRE)-- Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced that its co-founder and
About this update from Natera, Inc.
[{"type":"text","content":" AUSTIN, Texas--(BUSINESS WIRE)--\nNatera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced that its co-founder and executive chairman, Matthew Rabinowitz, PhD, has been named R&D Leader of the Year by R&D World.\n\n\nEstablished in 1963, the R&D 100 Awards program identifies and celebrates the top 100 revolutionary technologies of the past year. R&D World also has five professional awards given to individuals and/or teams, which in 2024, includes the award for Dr. Rabinowitz.\n\n\nIn awarding this honor, R&D World referred to Dr. Rabinowitz as a “pioneering figure in genetic testing and precision medicine.” The organization cited numerous achievements throughout his career at Natera, highlighting the company’s efforts to shape how diseases are detected and managed globally. This includes the development and launch of multiple transformational products, such as: Panorama™, a prenatal blood test that screens for common chromosomal conditions and has supported millions of healthy pregnancies worldwide; Signatera™, a blood test to detect cancer recurrence at a molecular level, which has helped hundreds of thousands of cancer patients; and Prospera™, a blood test that evaluates the risk of rejection of a transplanted kidney, heart, or lung.\n\n\nAs noted by R&D World, Dr. Rabinowitz holds numerous patents and has authored or co-authored multiple publications in prestigious journals. These include Nature, Science, Nature Medicine, The New England Journal of Medicine, JAMA Oncology, and The Journal of Clinical Oncology.\n\n\n“This is a tremendous honor, largely thanks to the dedicated teams who have transformed fields such as women’s health and cancer care,” said Dr. Rabinowitz. “At Natera, investing in R&D to drive innovation is a core part of our mission-driven heritage. I share this award with my extremely talented colleagues at Natera and my other companies, who have an unwavering commitment to the patient and family behind every sample. I’m happy to also congratulate my fellow R&D award recipients.”\n\n\nMatthew Rabinowitz: Biographical Information\n\n\nMatthew Rabinowitz is co-founder of Natera and currently serves as Executive Chairman of the Company’s board of directors. He served as Natera’s Chief Executive Officer from 2005 to 2019. He also serves as chairman of the board, director o...